APA

Landsburg D. J., Hughes M. E., Koike A., Bond D., Maddocks K. J., Guo L., Winter A. M., Hill B. T., Ondrejka S. L., Hsi E. D., Nasta S. D., Svoboda J., Schuster S. J. & Bogusz A. M. (20200109). Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy. : Blood advances.

Chicago

Landsburg Daniel J, Hughes Mitchell E, Koike Alexa, Bond David, Maddocks Kami J, Guo Ling, Winter Allison M, Hill Brian T, Ondrejka Sarah L, Hsi Eric D, Nasta Sunita D, Svoboda Jakub, Schuster Stephen J and Bogusz Agata M. 20200109. Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy. : Blood advances.

Harvard

Landsburg D. J., Hughes M. E., Koike A., Bond D., Maddocks K. J., Guo L., Winter A. M., Hill B. T., Ondrejka S. L., Hsi E. D., Nasta S. D., Svoboda J., Schuster S. J. and Bogusz A. M. (20200109). Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy. : Blood advances.

MLA

Landsburg Daniel J, Hughes Mitchell E, Koike Alexa, Bond David, Maddocks Kami J, Guo Ling, Winter Allison M, Hill Brian T, Ondrejka Sarah L, Hsi Eric D, Nasta Sunita D, Svoboda Jakub, Schuster Stephen J and Bogusz Agata M. Outcomes of patients with relapsed/refractory double-expressor B-cell lymphoma treated with ibrutinib monotherapy. : Blood advances. 20200109.